July 2014 Deals & Suits

Corporate Counsel

   | 0 Comments

Novartis
Glaxo
Eli Lilly

Novartis AG announced a major asset swap with GlaxoSmithKline plc as well as a agreement to sell its animal health unit to Eli Lilly & Co. on April 22. All told, the deals could be worth more than $30 billion.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202659667505

Thank you!

This article's comments will be reviewed.